---
$id: https://graph.org.ai/products/commodity/51141559
$type: Product
source: UNSPSC
code: "51141559"
title: "Loreclezole"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Loreclezole

**UNSPSC Code**: 51141559
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent with the molecular formula C10H6Cl3N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6DJ32STZ5W, chemically known as 1h-1,2,4-triazole, 1-(2-chloro-2-(2,4-dichlorophenyl)ethenyl)-, (z)- but generally known as loreclezole, which bears US NIH Compound Identifier 3034012. European Medicines Agency schedules Loreclezole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08586MIG. The term LORECLEZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). LORECLEZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule loreclezole under HS 29339990 and SITC 51577. As of Q4 2014, LORECLEZOLE remains the US FDA Preferred Term for this commodity. Loreclezole bears US NLM identifiers UMLS ID C0083257 and NCI Concept Code C66036. SMILES: C1=CC(=C(C=C1CL)CL)/C(=C/N2C=NC=N2)/CL.

